Biotech

All Articles

Fierce Biotech Editor-in-Chief Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Let's study a conversation with Ayla Ellison, Brutal Biotech Managing Editor and Michelle Benz as t...

New records demonstrate how Bayer's asundexian fell short to stop strokes

.Bayer put on hold the phase 3 trial for its own variable XIa prevention asundexian behind time in 2...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS tests

.Sanofi is still set on taking its numerous sclerosis (MS) med tolebrutinib to the FDA, managers hav...

Galapagos' stockpile as fund shows intent to form its advancement

.Galapagos is actually coming under added stress coming from entrepreneurs. Having actually built a ...

Cell- concentrated Sana scoops 1st CSO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings...

Allist pays Jacobio $21M, landing duty in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has gotten itself a starring job in China's KRAS market, paying for...

ReNeuron leaving objective substitution after overlooking fundraising objective

.ReNeuron has signed up with the lengthy checklist of biotechs to leave behind Greater london's obje...

MBX files for IPO to take challenger to Ascendis right into stage 3

.MBX Biosciences has contributed to the latest outbreak of IPO filings. The biotech, which filed its...

FDA increases probe into Lykos' MDMA tests: WSJ

.For Lykos Therapeutics and the business's would-be MDMA-assisted treatment for trauma (PTSD), the s...

Gene publisher Volume laying off 131 laborers

.Merely days after genetics publisher Volume Biosciences declared concealed working slices, a cleare...